Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits - Wikidata - awgldk - TriplyDB

Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits

Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits

http://www.wikidata.org/entity/Q34310872

about

Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 Provirus Molecular Mechanisms of HTLV-1 Cell-to-Cell Transmission Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis Recent Advances in BLV Research HTLV-1 ORF-I Encoded Proteins and the Regulation of Host Immune Response: Viral Induced Dysregulation of Intracellular Signaling How does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)?The need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission.Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins.Animal Models Utilized in HTLV-1 Research Co-dependence of HTLV-1 p12 and p8 functions in virus persistence Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival.Human T-lymphotropic type 1 virus p30 inhibits homologous recombination and favors unfaithful DNA repair.Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles.Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.Orf-I and orf-II-encoded proteins in HTLV-1 infection and persistence.Molecular determinants of human T-lymphotropic virus type 1 transmission and spread.HTLV-1 and innate immunity.Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion.Human T lymphotropic virus type 1 regulatory and accessory gene transcript expression and export are not rex dependent.The Tax-Inducible Actin-Bundling Protein Fascin Is Crucial for Release and Cell-to-Cell Transmission of Human T-Cell Leukemia Virus Type 1 (HTLV-1).What we are learning on HTLV-1 pathogenesis from animal models.Comparative host protein interactions with HTLV-1 p30 and HTLV-2 p28: insights into difference in pathobiology of human retroviruses.Pathways of cell-cell transmission of HTLV-1 Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells.PA28γ is a novel corepressor of HTLV-1 replication and controls viral latency.Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 Pathogenesis.Human T Cell Leukemia Virus Type 1 Infection of the Three Monocyte Subsets Contributes to Viral Burden in Humans.Cell-Free versus Cell-to-Cell Infection by Human Immunodeficiency Virus Type 1 and Human T-Lymphotropic Virus Type 1: Exploring the Link among Viral Source, Viral Trafficking, and Viral Replication.Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells.Animal models on HTLV-1 and related viruses: what did we learn?Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis Virological and immunological mechanisms in the pathogenesis of human T-cell leukemia virus type 1.Human T-lymphotropic virus type 1 non-structural proteins: Requirements for latent infection.DC-T cell virological synapses and the skin: novel perspectives in dermatology.HTLV-1 and HTLV-2: highly similar viruses with distinct oncogenic properties.A new role for the HTLV-1 p8 protein: increasing intercellular conduits and viral cell-to-cell transmission Viral Source-Independent High Susceptibility of Dendritic Cells to Human T-Cell Leukemia Virus Type 1 Infection Compared to That of T Lymphocytes.Comparison of the Genetic Organization, Expression Strategies and Oncogenic Potential of HTLV-1 and HTLV-2.Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody

P2860

Q26744327-5B9CEFDB-BBB5-4D6E-BCC4-C374C2721D15 Q26752562-834DEF2D-81FA-42B8-A472-26459FEFCD8A Q26765424-8E9EB766-A294-43EA-9268-653215BDC3CC Q26776531-E9143E9B-D6DD-46C5-B134-FDD4A0AE696C Q26777804-761B1F7A-FE68-4F1A-8C1C-CBF1EF227EEB Q26785554-33F229F8-F466-4343-B300-9DEB4196AC26 Q26864846-CF6328F0-76EB-492F-A9C7-A8B00A7193E8 Q30497545-E542656F-F084-44A2-B686-4FE7C0449976 Q34258809-D3A0406F-805B-4FC1-B86E-BFEFFF0F44E2 Q34463104-D3012765-9361-4973-91BB-562A999BC2FB Q34466396-15B74B13-80BF-47C8-B16A-761310268FCF Q34606461-FD4C2F15-D076-401B-8DD3-FF488CE084C5 Q35037411-563E5B3D-7047-4146-BC19-7AAEB6EC29D4 Q35164261-5EF4AE19-BD24-44D3-92A5-26CC4DE79F0E Q35261245-65D9BEE0-52A0-4375-A2DF-90155FCA6BF5 Q35261449-17A3C64B-2910-43B9-9421-6C6B1CF4585C Q35261463-375018C8-1EA8-44D9-B625-4758AFCD4694 Q35261692-4743681D-7539-463B-8197-11EAE0F4A024 Q35826764-C5C4966F-52AA-42FA-AF81-EB2F212A75AB Q35862299-45E6C118-B5C3-472A-8D4A-F921549EB979 Q36173231-D4A83F73-2336-4EDD-9D7C-A117979DF4AC Q36201405-2EA0D527-D3F2-44B2-A5B1-F9F29170728A Q36299426-F8C20706-C174-4C04-BB6F-287D8024B6B2 Q36343823-EE50C9D9-E5DE-43E8-9B06-641A59BA24BC Q36352268-673547C0-E225-4F52-9814-FCB1AC3DB6DE Q36584827-BA4D4BC2-00A8-4274-80F4-E8F8C64310C4 Q36694078-678505B3-08AC-4F55-B304-F0C599814748 Q36736791-883A1CB5-332D-480B-B174-73B3373F3597 Q37182721-AED61C54-8982-4CC3-80CB-C2D2769D3707 Q37547587-21A63A81-AB6F-4F9F-9D34-94D111BAED3E Q38050763-9A0DCAC4-697E-4670-83C1-EE18E9CEE425 Q38068180-E21CDFE9-D7AB-48D3-90BD-2A36B675685D Q38100771-EDC64303-34BF-47D4-9495-15D654AF3169 Q38104766-65AB49A7-3B40-426C-AB71-38C3C00E8E9A Q38231405-2AC4051C-5579-4294-887A-DEF1728CB4D6 Q38239657-CFDF89A4-5216-4C2A-B4BB-485C1554B953 Q38615299-81C7D912-5BE7-4ED9-8E3A-89529CA2F29D Q38844079-4DE3FA06-4ED2-46DC-9047-DEE94308126E Q39392791-BB058BF4-6240-4283-B6D2-656B3D6E47C5 Q40649807-5496EEBF-255C-4F50-BF0F-039EE744F6BC

P2860

Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits

http://www.wikidata.org/entity/Q34310872

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Requirement of the human T-cel ...... s and macaques but not rabbits

@ast

Requirement of the human T-cel ...... s and macaques but not rabbits

@en

Requirement of the human T-cel ...... s and macaques but not rabbits

@nl

type

label

Requirement of the human T-cel ...... s and macaques but not rabbits

@ast

Requirement of the human T-cel ...... s and macaques but not rabbits

@en

Requirement of the human T-cel ...... s and macaques but not rabbits

@nl

prefLabel

Requirement of the human T-cel ...... s and macaques but not rabbits

@ast

Requirement of the human T-cel ...... s and macaques but not rabbits

@en

Requirement of the human T-cel ...... s and macaques but not rabbits

@nl

P1433

Q34310872-88749D31-0AB4-4CD1-8FD8-B3F89A531EC6

P1476

Q34310872-331E360E-CA09-4F35-9A79-73809051DC46

P2093

Q34310872-607931C6-D3E0-4A02-936D-0FACDAC918A4

Q34310872-6AAE68BC-E1A3-4774-8294-B2A9C273E9E8

Q34310872-7AB17434-2E96-4CCE-B30D-597EA249E23F

Q34310872-9C7D2F96-2232-4860-A7DA-2A42E249EE47

Q34310872-A90DF0D5-6603-41DC-B4AC-2307A8FB4A44

Q34310872-AFA2B943-562B-42D4-B2E5-ED43B14B862B

Q34310872-C9470C9F-257A-4A67-9823-8172321F5796

Q34310872-EF4084CB-DA24-467F-BDBF-65A17AE3F7C8

Q34310872-F904E3BC-2FF2-40A7-861C-0E572BF9B1EB

Q34310872-FEE8A340-1C03-4507-94F5-81A69D0BCFC6

P2860

Q34310872-05DC127D-5D67-4D3E-B2C1-DCD0C28847A6

Q34310872-0DF85A6E-3E18-4903-A147-424A71FB1655

Q34310872-1EFC8DBB-6AD9-4900-BFD4-71DDB655CDE3

Q34310872-27BDD795-EA36-48F8-B1FF-2E285B3BF8F5

Q34310872-2C417EED-57DA-4894-B30F-08655789871C

Q34310872-2FF877FA-79A5-453D-AEE3-B5CFBDBA7F22

Q34310872-30C3AB3A-8AAC-4A84-8DB5-FB316DBCAA35

Q34310872-32967BA7-A0E5-4250-BB11-ABADDA7AE0B8

Q34310872-34D8D22B-84D7-468F-8780-7A3062CE4D4C

Q34310872-35BE8F1D-0EBD-46C1-8FB1-FA167D799B2F

P304

Q34310872-28EAA2F6-8F5F-45E8-980A-4F493417E64C

P31

Q34310872-0ABC6BBE-3664-48EC-B4CC-317CEB2CE7BD

P356

Q34310872-D2D2D5F9-F3E2-423A-A646-968C42F5272C

P407

Q34310872-1A03E3E4-6CAE-44F9-BB82-EFF3B1E71C31

P433

Q34310872-CE362004-DE40-405B-B20C-92A81489FC3E

P478

Q34310872-2A6A08AD-95CB-4D1E-94E1-C6FCE9D1BEE6

P50

Q34310872-024AC9D9-00D9-46FD-BFBF-996D044F819E

Q34310872-70A1945E-E16E-47C4-93ED-ECA7DCDFA1D6

Q34310872-DBC980C8-0A20-4C6A-B3E1-E458A4944B3A

P577

Q34310872-94323E8F-3BC3-4F6E-AB06-58B2C41F60F8

P5875

Q34310872-FCD71CFA-F04F-4D4B-B136-B2F8020520DB

P698

Q34310872-7AB5F839-9AB4-446F-A482-A9D4EDAB4A3A

P921

Q34310872-38C4BA32-0FD9-49D7-94D9-994340160345

P932

Q34310872-EAAE63F1-841D-4E26-8DB2-D065B178A84A

P356

BLOOD-2010-05-284141

P1433

P1476

Requirement of the human T-cel ...... s and macaques but not rabbits

@en

P2093

Christophe Nicot

http://www.w3.org/2001/XMLSchema#string

Frank Ruscetti

http://www.w3.org/2001/XMLSchema#string

Genoveffa Franchini

http://www.w3.org/2001/XMLSchema#string

Hye Kyung Chung

http://www.w3.org/2001/XMLSchema#string

Kathy Jones

http://www.w3.org/2001/XMLSchema#string

Maria Grazia Ferrari

http://www.w3.org/2001/XMLSchema#string

Risaku Fukumoto

http://www.w3.org/2001/XMLSchema#string

Robyn Washington Parks

http://www.w3.org/2001/XMLSchema#string

Valentina Cecchinato

http://www.w3.org/2001/XMLSchema#string

Valerio W Valeri

http://www.w3.org/2001/XMLSchema#string

P2860

Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite th

A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactions

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein

Genome wide analysis of human genes transcriptionally and post-transcriptionally regulated by the HTLV-I protein p30.

Multiple control levels of cell proliferation by human T-cell leukemia virus type 1 Tax protein.

HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro.

Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.

Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters.

Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.

P304

3809-3817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2010-05-284141

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Anna Hryniewicz

Claudio Fenizia

P577

2010-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45278679

http://www.w3.org/2001/XMLSchema#string

P698

20647569

http://www.w3.org/2001/XMLSchema#string

P921

P932

2981536

http://www.w3.org/2001/XMLSchema#string